DAVITA INC. — Director's Dealing 2016

Jul 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-07-01

Reporting Person: JIGANTI JEANINE MARIE (Chief Compliance Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-01	Common Stock	M	2812	$48.68	Acquired	7590	Direct
2016-07-01	Common Stock	F	1771	$77.32	Disposed	5819	Direct
2016-07-01	Common Stock	S	1041	$77.3810	Disposed	4778	Direct
2016-07-01	Common Stock	M	7500	$53.16	Acquired	12278	Direct
2016-07-01	Common Stock	F	5157	$77.32	Disposed	7121	Direct
2016-07-01	Common Stock	S	2343	$77.4599	Disposed	4778	Direct
2016-07-01	Common Stock	M	5200	$58.94	Acquired	9978	Direct
2016-07-01	Common Stock	F	3964	$77.32	Disposed	6014	Direct
2016-07-01	Common Stock	S	1236	$77.5016	Disposed	4778	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-01	Stock Appreciation Rights	$48.68	M	2812	Disposed	2017-07-09	Common Stock (2812)	Direct
2016-07-01	Stock Appreciation Rights	$53.16	M	7500	Disposed	2017-12-05	Common Stock (7500)	Direct
2016-07-01	Stock Appreciation Rights	$58.94	M	5200	Disposed	2018-03-19	Common Stock (5200)	Direct

Footnotes

F1: The exercises and sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2016.

F2: Represents the weighted average sale price of $77.3810. The range of prices for the sale of these shares was $77.36 - $77.40, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average sale price of $77.4599. The range of prices for the sale of these shares was $77.40 - $77.50, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: Represents the weighted average sale price of $77.5016. The range of prices for the sale of these shares was $77.50 - $77.52, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number shares sold at each separate price.

F5: The Stock Appreciation Rights were granted on 7/9/2012. 25% vested on 7/9/2013, then 6.25% vested every three months thereafter.

F6: The Stock Appreciation Rights were granted on 12/5/2012. 50% vested on 12/5/2015 and the remaining 50% will vest on 12/5/2016.

F7: The Stock Appreciation Rights were granted on 3/19/2013. 50% vested on 3/19/2016 and the remaining 50% will vest on 3/19/2017.